back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-04-07 11:04 Tx date 2026-04-06 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-20,184.50
-3,950 vol $5.11 each |
10,855 | |
| Filed 2026-04-07 11:00 Tx date 2026-04-01 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-743,000
-100,000 vol $7.43 each |
14,805 | |
| Older filings | ||||||
| Filed 2026-04-01 16:02 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: Samantha Nutt (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+16,666 vol |
16,666 | |
| Filed 2026-04-01 16:01 Tx date 2023-06-29 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: Samantha Nutt (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-04-01 16:00 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: Samantha Nutt (Indirect Ownership)
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
11 - Acquisition or disposition carried out privately
|
+$50,000 vol |
$50,000 | |
| Filed 2026-04-01 16:00 Tx date 2023-06-29 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: Samantha Nutt (Indirect Ownership)
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-04-01 15:58 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$16,667,000
+16,667 vol $1,000 each |
516,667 | |
| Filed 2026-04-01 15:57 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
16 - Acquisition or disposition under a prospectus exemption
|
$
+$50,000 vol $1,000 each |
$50,000 | |
| Filed 2026-03-23 16:09 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$33,333,000
+33,333 vol $1,000 each |
||
| Filed 2026-03-23 16:03 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100,000 vol $1,000 each |
||
| Filed 2026-03-23 16:23 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
16 - Acquisition or disposition under a prospectus exemption
|
$300,000
+100,000 vol $3.00 each |
233,212 | |
| Filed 2026-03-23 16:22 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
16 - Acquisition or disposition under a prospectus exemption
|
$300,000
+100,000 vol $3.00 each |
||
| Filed 2026-03-23 16:20 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
16 - Acquisition or disposition under a prospectus exemption
|
$300,000
+100,000 vol $3.00 each |
114,805 | |
| Filed 2026-03-23 16:19 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
16 - Acquisition or disposition under a prospectus exemption
|
$300,000
+100,000 vol $3.00 each |
143,919 | |
| Filed 2026-03-23 16:17 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
16 - Acquisition or disposition under a prospectus exemption
|
$300,000
+100,000 vol $3.00 each |
||
| Filed 2026-03-23 16:10 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$66,666,000
+66,666 vol $1,000 each |
66,666 | |
| Filed 2026-03-23 16:09 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$33,333,000
+33,333 vol $1,000 each |
533,333 | |
| Filed 2026-03-23 16:07 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$66,666,000
+66,666 vol $1,000 each |
||
| Filed 2026-03-23 16:04 Tx date 2023-06-29 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-23 16:03 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100,000 vol $1,000 each |
$100,000 | |
| Filed 2026-03-23 16:01 Tx date 2023-06-29 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-23 16:01 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
16 - Acquisition or disposition under a prospectus exemption
|
$
+$200,000 vol $1,000 each |
$200,000 | |
| Filed 2026-03-23 15:59 Tx date 2023-06-29 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-17 17:13 Tx date 2026-03-12 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
$42,342
+14,805 vol $2.86 each |
14,805 | |
| Filed 2026-03-17 17:12 Tx date 2026-03-12 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-91,520
-32,000 vol $2.86 each |
0 | |
| Filed 2026-03-17 17:07 Tx date 2026-03-12 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
$42,342
+14,805 vol $2.86 each |
43,919 | |
| Filed 2026-03-17 17:05 Tx date 2026-03-12 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-91,520
-32,000 vol $2.86 each |
0 | |
| Filed 2026-03-17 16:55 Tx date 2026-03-12 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
$42,342
+14,805 vol $2.86 each |
133,212 | |
| Filed 2026-03-17 16:54 Tx date 2026-03-12 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-91,520
-32,000 vol $2.86 each |
0 | |
| Filed 2026-03-17 16:18 Tx date 2026-03-12 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
$42,342
+14,805 vol $2.86 each |
||
| Filed 2026-03-17 16:17 Tx date 2026-03-12 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-42,342.30
-14,805 vol $2.86 each |
||
| Filed 2025-12-11 12:53 Tx date 2025-12-10 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Holder: Xorax Family Trust (Indirect Ownership)
|
Multiple Voting Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$375.00
+15 vol $25.00 each |
21 | |
| Filed 2025-12-11 12:51 Tx date 2025-12-10 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Fortius Research and Trading Corp. (Indirect Ownership)
|
Multiple Voting Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$375.00
+15 vol $25.00 each |
21 | |
| Filed 2025-11-26 16:55 Tx date 2025-11-26 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-6,655
-500 vol $13.31 each |
0 | |
| Filed 2025-11-26 16:54 Tx date 2025-11-26 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-68,415.94
-6,967 vol $9.82 each |
500 | |
| Filed 2025-11-26 16:54 Tx date 2025-11-25 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-94,220
-14,000 vol $6.73 each |
7,467 | |
| Filed 2025-11-26 16:53 Tx date 2025-11-24 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-81,250
-13,000 vol $6.25 each |
21,467 | |
| Filed 2025-11-21 16:22 Tx date 2025-11-21 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-46,880
-8,000 vol $5.86 each |
34,467 | |
| Filed 2025-11-21 16:22 Tx date 2025-11-20 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-100,480
-16,000 vol $6.28 each |
42,467 | |
| Filed 2025-11-21 16:21 Tx date 2025-11-18 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-134,480.85
-21,245 vol $6.33 each |
58,467 | |
| Filed 2025-11-21 16:21 Tx date 2025-11-18 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-41,358
-6,100 vol $6.78 each |
79,712 | |
| Filed 2025-11-21 16:20 Tx date 2025-11-17 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-39,423
-5,100 vol $7.73 each |
85,812 | |
| Filed 2025-10-29 22:06 Tx date 2025-10-29 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Jacqueline Burns (Indirect Ownership)
|
Subordinate Voting Shares Class B
90 - Change in the nature of ownership
|
-647 vol |
0 | |
| Filed 2025-10-29 22:05 Tx date 2025-10-29 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
11 - Acquisition or disposition carried out privately
|
-77,000 vol |
29,114 | |
| Filed 2025-10-01 11:21 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 15:35 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 15:34 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 15:31 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Bashir, Muhammad Adnan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 15:31 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Bashir, Muhammad Adnan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 15:30 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
14,692 | |
| Filed 2025-09-30 15:29 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 15:29 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 15:28 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 15:27 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
57,000 | |
| Filed 2025-09-30 15:26 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 15:25 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 15:25 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+32,000 vol |
32,000 | |
| Filed 2025-09-30 15:24 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+32,000 vol |
||
| Filed 2025-09-30 15:24 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 15:24 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 15:23 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+32,000 vol |
32,000 | |
| Filed 2025-09-30 15:23 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+32,000 vol |
||
| Filed 2025-09-30 15:22 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 15:22 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 15:20 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+32,000 vol |
32,000 | |
| Filed 2025-09-30 15:19 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+32,000 vol |
||
| Filed 2025-09-30 15:19 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 13:02 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Bashir, Muhammad Adnan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 13:02 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Bashir, Muhammad Adnan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 12:53 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 12:53 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 12:50 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
14,692 | |
| Filed 2025-09-30 12:50 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 12:49 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 12:49 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 12:49 Tx date 2023-06-29 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-30 12:45 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
57,000 | |
| Filed 2025-09-30 12:45 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 12:43 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 12:43 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 12:42 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+32,000 vol |
||
| Filed 2025-09-30 12:42 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+32,000 vol |
32,000 | |
| Filed 2025-09-30 12:41 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 12:41 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 12:40 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+32,000 vol |
32,000 | |
| Filed 2025-09-30 12:40 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+32,000 vol |
||
| Filed 2025-09-30 12:38 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 12:38 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 12:37 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+32,000 vol |
32,000 | |
| Filed 2025-09-30 12:37 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+32,000 vol |
||
| Filed 2025-08-07 11:50 Tx date 2025-08-07 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$7,950
+300 vol $26.50 each |
118,407 | |
| Filed 2025-07-17 17:12 Tx date 2025-07-17 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$15,925
+700 vol $22.75 each |
106,114 | |
| Filed 2025-07-14 19:10 Tx date 2025-07-14 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$14,608
+500 vol $29.22 each |
90,912 | |
| Filed 2025-06-18 15:27 Tx date 2025-06-05 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
36 - Conversion or exchange
|
+51,417 vol |
51,417 | |
| Filed 2025-06-18 15:26 Tx date 2025-06-05 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
36 - Conversion or exchange
|
-$330,000 vol |
$0 | |
| Filed 2025-06-18 15:25 Tx date 2025-06-05 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
36 - Conversion or exchange
|
-$330,000 vol |
||
| Filed 2025-06-18 15:23 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-18 15:23 Tx date 2025-06-05 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
36 - Conversion or exchange
|
-$330,000 vol |
||
| Filed 2025-06-18 15:09 Tx date 2025-03-28 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+25,080 vol |
25,080 | |
| Filed 2025-06-18 15:05 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-18 15:05 Tx date 2025-03-28 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
+$330,000 vol |
$330,000 | |
| Filed 2025-06-18 15:02 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-18 15:01 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-18 14:55 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
$330,000 | ||
| Filed 2025-06-18 14:55 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-18 14:48 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2025-06-14 13:02 Tx date 2024-08-23 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-35,000 vol |
0 | |
| Filed 2025-06-14 12:59 Tx date 2024-08-15 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-2,462 vol |
38 | |
| Filed 2025-06-13 18:03 Tx date 2025-06-03 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-60,480
-3,000 vol $20.16 each |
2,500 | |
| Filed 2025-06-13 18:00 Tx date 2025-06-02 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$15,750
+3,000 vol $5.25 each |
5,500 | |
| Filed 2025-06-13 17:57 Tx date 2025-06-02 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,750
-3,000 vol $5.25 each |
35,000 | |
| Filed 2025-04-07 15:43 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
105,414 | |
| Filed 2025-04-07 15:42 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
0 | |
| Filed 2025-04-07 15:40 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
15,628 | |
| Filed 2025-04-07 15:40 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
0 | |
| Filed 2025-04-07 15:39 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
0 | |
| Filed 2025-04-07 15:38 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
118,107 | |
| Filed 2025-04-07 15:37 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-07 15:37 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-07 15:24 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
90,412 | |
| Filed 2025-04-07 15:23 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
0 | |
| Filed 2025-04-03 15:18 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-03 15:17 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
$88,458
+7,692 vol $11.50 each |
||
| Filed 2025-04-03 15:16 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-03 15:14 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
||
| Filed 2025-04-03 15:13 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
||
| Filed 2025-04-03 15:13 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-03 15:10 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
||
| Filed 2025-04-03 15:09 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
58 - Expiration of rights
|
-7,692 vol |
||
| Filed 2025-04-03 15:18 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
0 | |
| Filed 2025-04-03 15:17 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
$88,458
+7,692 vol $11.50 each |
90,412 | |
| Filed 2025-04-03 15:16 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-03 15:14 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
||
| Filed 2025-04-03 15:13 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
||
| Filed 2025-04-03 15:13 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-03 15:10 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
||
| Filed 2025-04-03 15:09 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
58 - Expiration of rights
|
-7,692 vol |
||
| Filed 2025-03-11 17:55 Tx date 2024-08-15 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-492,308 vol |
7,692 | |
| Filed 2025-03-11 17:41 Tx date 2025-03-07 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,767
+7,692 vol $6.60 each |
7,692 | |
| Filed 2025-03-11 17:38 Tx date 2025-03-07 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,767
+7,692 vol $6.60 each |
||
| Filed 2025-03-10 17:11 Tx date 2025-03-07 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,767
+7,692 vol $6.60 each |
||
| Filed 2025-03-10 17:22 Tx date 2025-02-26 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Warrants
97 - Other
|
-7,692 vol |
492,308 | |
| Filed 2025-03-10 17:11 Tx date 2025-03-07 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,767
+7,692 vol $6.60 each |
7,692 | |
| Filed 2025-03-10 17:09 Tx date 2023-06-29 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-02-07 16:51 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$-109,515
-4,900 vol $22.35 each |
436 | |
| Filed 2025-02-07 16:51 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$-59,098
-2,600 vol $22.73 each |
5,336 | |
| Filed 2025-02-07 16:50 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$39,375
+7,500 vol $5.25 each |
7,936 | |
| Filed 2025-02-07 16:50 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-39,375
-7,500 vol $5.25 each |
0 | |
| Filed 2025-02-07 16:49 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-39,375
-7,500 vol $5.25 each |
||
| Filed 2025-02-07 16:49 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$109,515
+4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:49 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$-59,098
-2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:49 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$39,375
+7,500 vol $5.25 each |
||
| Filed 2025-02-07 16:48 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$109,515
+4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:47 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$-59,098
-2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:39 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$39,375
+7,500 vol $5.25 each |
||
| Filed 2025-02-07 16:38 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-39,375
-7,500 vol $5.25 each |
||
| Filed 2025-02-07 16:37 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-59,098
-2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:37 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-109,515
-4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:36 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$109,515
+4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:36 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$59,098
+2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:11 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$109,515
+4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:11 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-109,515
-4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:10 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$59,098
+2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:09 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-59,098
-2,600 vol $22.73 each |
||